Hervana Bio is a biopharmaceutical company that develops womens health products. The company has developed a female contraceptive platform technology that is non-hormonal and offers protection against sexually transmitted infections.
Hervanas LJ-102 is a highly effective, long-lasting contraceptive technology free from the drawbacks of current hormone-based contraceptives. The products safety profile and prolonged action enable greater compliance and accessibility, particularly in populations where the available methods of contraception are contraindicated, undesirable, or socially unacceptable.
In 2012, Hervana Bio received a $1 million grant from the Bill and Melinda Gates Foundation.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Hervana Bio Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Apr 3, 2024
www.calcalistech.com
The Israeli startup developing the first new, non-hormonal contraceptive in 60 years | CTech
#Investment
Jan 31, 2018
www.prweb.com
Hervana Bio Founder and CEO Dr. Rachel Teitelbaum Provides Update on Female Contraceptive Development at Microbiome EU Summit